Rapid Therapeutic Science Laboratories Inc (PCHA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PCHA Annual Balance Sheets →
This balance sheet overview for Rapid Therapeutic Science Laboratories Inc spans from Jun 30 2022 to Jun 30 2023, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Value Added Tax Receivable, Current0.08
Inventories0.18
Prepaid Expense, Current AS0.06
Total Current Assets0.32
Equipment/Property/Plant Net1.29
Intangible Assets0.17
Other Assets, Noncurrent0.30
Operating Lease Right Of Use Asset0.30
Total Assets2.07
Liabilities
Accrued Liabilities, Current0.77
Financial Instruments0.03
Notes Payable, Current NO0.84
Other Liabilities, Current2.78
Total Current Liabilities4.43
Convertible Notes Payable NO0.15
Total Long-term Debt0.15
Other liabilities, Noncurrent0.24
Operating Lease Liability Current0.10
Total Liabilities4.81
Stockholders' Equity
Common Stock Value0.01
Treasury Stock Value-0.34
Additional Paid In Capital Common Stock7.67
Retained Earnings / Accumulated Deficit-10.08
Other Equity0.00
Common Stockholder's Equity-2.74
Total Stockholder's Equity-2.74
Liabilities & Stockholder's Equity2.07
4 historic quarters locked

Sign in to unlock the full Rapid Therapeutic Science Laboratories Inc balance sheet history.

About Rapid Therapeutic Science Laboratories Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001393905-23-000312

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.